Supplemental material
Leukemia & Lymphoma
Volume 64, 2023 - Issue 14
Open access
1,890
Views
0
CrossRef citations to date
0
Altmetric
Original Articles
Comparative effectiveness between mosunetuzumab monotherapy clinical trial and real-world data in relapsed/refractory follicular lymphoma in third or subsequent lines of systemic therapy
Sarah F. McGougha Genentech, Inc., South San Francisco, California, USACorrespondence[email protected]
View further author information
, View further author information
Natasha Shamasa Genentech, Inc., South San Francisco, California, USAView further author information
, Jue Wanga Genentech, Inc., South San Francisco, California, USAView further author information
, Mahmoud Jaberb F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
, Binay Swarupb F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
, Marie-Hélène Blanchet Zumofenb F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
, Bertrand Lautiéb F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
, Joana Parreirab F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
, Michael C. Weia Genentech, Inc., South San Francisco, California, USAView further author information
& Ashwini Shewadea Genentech, Inc., South San Francisco, California, USAView further author information
show all
Pages 2269-2278
|
Received 05 Apr 2023, Accepted 14 Sep 2023, Published online: 15 Oct 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.